Showing results (91-100 of 1,408) with videos related to
Sort By:
Pageof 141
NPJ Parkinson'S Disease|May 13, 2022
Parkinson's disease clinical milestones and mortalityMaria Camila Gonzalez, Ingvild Dalen, Jodi Maple-Grødem, et al.NPJ Parkinson'S Disease|July 21, 2021
TNFα increases tyrosine hydroxylase expression in human monocytesAdithya Gopinath, Martin Badov, Madison Francis, et al.NPJ Parkinson'S Disease|May 24, 2022
Probiotics synergized with conventional regimen in managing Parkinson's diseaseHairong Sun, Feiyan Zhao, Yuanyuan Liu, et al.NPJ Parkinson'S Disease|May 25, 2022
The macular inner plexiform layer thickness as an early diagnostic indicator for Parkinson's diseaseXin Wang, Bin Jiao, Xiaoliang Jia, et al.NPJ Parkinson'S Disease|July 23, 2021
Lateralized effects of deep brain stimulation in Parkinson's disease: evidence and controversiesZhengyu Lin, Chencheng Zhang, Dianyou Li, et al.NPJ Parkinson'S Disease|July 3, 2021
Parkinson's disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegenerationG Carola, D Malagarriga, C Calatayud, et al.NPJ Parkinson'S Disease|June 30, 2021
Impaired reach-to-grasp kinematics in parkinsonian patients relates to dopamine-dependent, subthalamic beta burstsMatteo Vissani, Chiara Palmisano, Jens Volkmann, et al.NPJ Parkinson'S Disease|July 2, 2021
A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson's diseaseCamilla Christina Pedersen, Johannes Lange, Marthe Gurine Gunnarsdatter Førland, et al.NPJ Parkinson'S Disease|June 9, 2021
Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson diseaseStefanie T Jost, Veerle Visser-Vandewalle, Alexandra Rizos, et al.NPJ Parkinson'S Disease|December 5, 2019
Advance care planning in Parkinson's disease: ethical challenges and future directionsLeonard L Sokol, Michael J Young, Jack Paparian, et al.Pageof 141